Saba Capital Management »

Arbutus Biopharma shares owned by Saba Capital Management

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Saba Capital Management from 13F filings

Historical chart of Saba Capital Management investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by Saba Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by Saba Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $964k 374k 2.58

More positions owned by Saba Capital Management

Ishares Tr Russell 2000 Etf Call Option (IWM)
Blackrock Esg Cap Allc Term Shs Ben Int (ECAT)
Blackrock Innovation And Grw Shs Ben Int (BIGZ)
Blackrock Health Sciences Te Com Shs (BMEZ)
Blackrock Capital Allocation Trust (BCAT)
Adams Express Company (ADX)
Pimco Dynamic Income Strateg Com Shs Ben Int (PDX)
ClearBridge Energy MLP Fund (EMO)
Blackrock Science & Technolo Shs Ben Int (BSTZ)
Clearbridge Mlp And Mids (CEM)
Nuveen CA Dividend Advantage Muni. Fund (NAC)
Nuveen Nj Div Advantage Mun (NXJ)
Mainstay Cbre Global (MEGI)
American Airls Put Option (AAL)
Blackrock Calif Mun Income T Sh Ben Int (BFZ)

View all positions for Saba Capital Management

Top funds holding Arbutus Biopharma

Whitefort Capital Management
BlackRock
Morgan Stanley
Two Seas Capital
Vanguard Group
FourWorld Capital Management
Woodline Partners
Hudson Bay Capital Management
Adage Capital Partners GP
Geode Capital Management
Citadel Advisors
ADAR1 Capital Management
BlackBarn Capital Partners
Centiva Capital
Squarepoint Ops

View all funds holding Arbutus Biopharma